SBRT and hormone therapy for intermediate-risk prostate cancer
Part of Cancer, Kidney & urinary, Mental health clinical trials.
This study tests a new combination of radiation (SBRT) and short-term hormone therapy (6 months) to see how it affects sexual function in men with unfavorable intermediate-risk prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 80 years old
- You have intermediate-risk prostate cancer (Gleason 7 with 4+3 pattern, PSA between 10–20, or stage T2b/T2c)
- You have not had pelvic radiation, prostate surgery, hormone therapy, or chemotherapy before
- You still have some erectile function (able to get an erection at least sometimes, even if not always firm enough for intercourse)
- Your general health is good (you can do normal daily activities without help)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of focused radiation therapy for men with intermediate or high-risk prostate cancer that hasn't spread. It aims to improve outcomes by targeting the main tumor seen on MRI.
This trial tests a type of radiation that adjusts to changes in your prostate during treatment. It aims to improve accuracy and reduce side effects for men with intermediate- or high-risk prostate cancer.
This trial studies a more sped-up radiation schedule for men with certain local prostate cancers, given together with hormone therapy. It aims to keep cancer control while possibly reducing treatment time and making care easier.
This trial tests whether giving a short course of hormone therapy (apalutamide) along with targeted, high-dose radiation (SBRT) is safe and effective for men with a specific type of intermediate-risk prostate cancer. You may benefit if you fit the exact risk and test criteria.
This study tests whether a combination of short-term hormone therapy (relugolix) and focused radiation (SBRT) can treat a certain type of prostate cancer that is considered favorable but has a higher genetic risk. It aims to find a less intense treatment that still works well.
This trial tests combining hormone therapy with different types of radiation (including high-dose external beam and brachytherapy) for men with prostate cancer that has a higher chance of coming back. It aims to see if adding radiation to the lymph nodes helps control the cancer better.
Hear when a new Prostate Cancer (Adenocarcinoma) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.